Mandate

Vinge represents Gambro in the sale of Gambro Healthcare

May 10, 2007

Vinge is representing Gambro in the sale of Gambro Healthcare to Bridgepoint. The sale of Gambro Healthcare was a part of the plan that was implemented when Investor and EQT acquired Gambro in June 2006. The sale requires the approval of the EU Commission before it can be concluded.
 
The partner in charge is Fredrik von Baumgarten, who is assisted by associates Tuula Tallavaara, Ulrich Ziche, Marion Ehman and Martin Hall. For financial matters, Gambro is represented by Fabian Ekeblad, together with Ann Bokinge and Hanna Fanning.

Related

Vinge has advised Behold Ventures in the fundraising of Behold Ventures’ first-time fund

Behold Ventures held its final closing on 27 June 2025, thereby securing investor commitments to its first-time fund amounting to approximately SEK 550 million from an international investor base, comprising the European Investment Fund (EIF), among others.
July 10, 2025

Vinge advises Main Capital in connection with the sale of Alfa eCare

Vinge has advised Main Capital in connection with the sale of Alfa eCare Holding AB and its subsidiaries (“Alfa eCare”) to SDB Groep B.V. (“SDB”)
July 10, 2025

Vinge is advising on the establishment of Ballista Capital

Ballista Capital held its final closing on 9 June 2025. The investor base primarily comprises family offices and investors with strong ties to northern Sweden.
July 07, 2025